Literature DB >> 33682667

Bovine respiratory disease treatment failure: definition and impact.

Calvin W Booker1.   

Abstract

Bovine respiratory disease (BRD) treatment failure occurs when animals receiving a treatment regimen for BRD fail to directly return to health, resulting in chronic illness and a requirement for repeated treatments, sale for salvage slaughter, euthanasia or death. BRD treatment failure has both direct and indirect impacts. Direct impacts include costs to manage chronically ill animals, including those associated with BRD relapse treatment; reduced returns from animals sent for salvage slaughter, loss of the initial investment to purchase the animal and feed and other accumulated expenses to death, and costs associated with carcass disposal. Indirect impacts include costs of infrastructure requirements, and negative effects on animal welfare and employee morale.

Entities:  

Keywords:  BRD; Bovine respiratory disease; cattle; impacts; treatment failure

Mesh:

Substances:

Year:  2020        PMID: 33682667     DOI: 10.1017/S146625232000016X

Source DB:  PubMed          Journal:  Anim Health Res Rev        ISSN: 1466-2523            Impact factor:   2.615


  2 in total

1.  Assessment of animal diseases caused by bacteria resistant to antimicrobials: cattle.

Authors:  Søren Saxmose Nielsen; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; Jose Luis Gonzales Rojas; Christian Gortazar Schmidt; Mette Herskin; Virginie Michel; Miguel Angel Miranda Chueca; Barbara Padalino; Paolo Pasquali; Helen Clare Roberts; Hans Spoolder; Karl Stahl; Antonio Velarde; Arvo Viltrop; Christoph Winckler; Jeroen Dewulf; Luca Guardabassi; Friederike Hilbert; Rodolphe Mader; Francesca Baldinelli; Julio Alvarez
Journal:  EFSA J       Date:  2021-12-10

2.  Evaluating the potential of third generation metagenomic sequencing for the detection of BRD pathogens and genetic determinants of antimicrobial resistance in chronically ill feedlot cattle.

Authors:  Claire N Freeman; Emily K Herman; Jennifer Abi Younes; Dana E Ramsay; Nathan Erikson; Paul Stothard; Matthew G Links; Simon J G Otto; Cheryl Waldner
Journal:  BMC Vet Res       Date:  2022-06-02       Impact factor: 2.792

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.